Recognizing Basic Science Contributions

A “basic bibliography” for new drugs would provide scientists with soft incentives and acknowledge the value of basic biomedical research.

| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

© SAGE 78/ISTOCKPHOTO.COMBasic biomedical research is key to conquering communicable diseases, which can spread rapidly around the globe, and the noncommunicable conditions behind the premature deaths of an increasing number of people. Many scholars believe that there is a correlation between support for fundamental biomedical research and the improvement of health outcomes, even though knowledge gleaned from basic research usually takes several decades to be applied in the clinic.

Basic research has traditionally been funded in great part by public money. Both small, investigator-initiated studies and large collaborative scientific projects, such as the mapping of the human genome, would have not been possible without public financial support. Unfortunately, however, basic research in the life sciences is usually underfunded.

In the United States, National Institutes of Health funding for all biomedical research has remained relatively stagnant since 2003. And in some countries, basic biomedical research now receives less support than it did just a few years ago.

With limited national budgets, it has become increasingly important to extract maximum transformative value for every biomedical research dollar, and it is necessary to determine how best to incorporate the relative merits of basic biomedical science with its ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • David Hemenway

    This person does not yet have a bio.
  • Andrea Ballabeni

    This person does not yet have a bio.
  • Andrea Boggio

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo